Mortality risk of antipsychotic augmentation for adult depression.

Mortality risk of antipsychotic augmentation for adult depression.

Show other versions (1)

<h4>Importance</h4>Randomized controlled trials have demonstrated increased all-cause mortality in elderly patients with dementia treated with newer antipsychotics. It is unknown whether this risk generalizes to non-elderly adults using newer antipsychotics as augmentation treatment for...

Full description

Bibliographic Details
Main Authors: Tobias Gerhard, T Scott Stroup, Christoph U Correll, Soko Setoguchi, Brian L Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal, Mark Olfson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0239206

Internet

https://doi.org/10.1371/journal.pone.0239206

Similar Items